[go: up one dir, main page]

GB202218142D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB202218142D0
GB202218142D0 GBGB2218142.4A GB202218142A GB202218142D0 GB 202218142 D0 GB202218142 D0 GB 202218142D0 GB 202218142 A GB202218142 A GB 202218142A GB 202218142 D0 GB202218142 D0 GB 202218142D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2218142.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vaccine Group Ltd
Original Assignee
Vaccine Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaccine Group Ltd filed Critical Vaccine Group Ltd
Priority to GBGB2218142.4A priority Critical patent/GB202218142D0/en
Publication of GB202218142D0 publication Critical patent/GB202218142D0/en
Priority to PCT/EP2023/084025 priority patent/WO2024115785A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/10011—Arenaviridae
    • C12N2760/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB2218142.4A 2022-12-02 2022-12-02 Vaccine Ceased GB202218142D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2218142.4A GB202218142D0 (en) 2022-12-02 2022-12-02 Vaccine
PCT/EP2023/084025 WO2024115785A1 (en) 2022-12-02 2023-12-02 Vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2218142.4A GB202218142D0 (en) 2022-12-02 2022-12-02 Vaccine

Publications (1)

Publication Number Publication Date
GB202218142D0 true GB202218142D0 (en) 2023-01-18

Family

ID=84926527

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2218142.4A Ceased GB202218142D0 (en) 2022-12-02 2022-12-02 Vaccine

Country Status (2)

Country Link
GB (1) GB202218142D0 (en)
WO (1) WO2024115785A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2155777A2 (en) * 2007-04-10 2010-02-24 The Administrators of the Tulane Educational Fund Soluble and membrane-anchored forms of lassa virus subunit proteins
GB201801437D0 (en) * 2018-01-29 2018-03-14 Sec Dep For Health Lassa virus antigenic composition
GB201906104D0 (en) 2019-05-01 2019-06-12 Univ Plymouth Intrinsic systems for viral vector transgene regulation

Also Published As

Publication number Publication date
WO2024115785A1 (en) 2024-06-06

Similar Documents

Publication Publication Date Title
GB2594365B (en) Coronavirus vaccine
GB202010425D0 (en) Combination vaccine
GB202002166D0 (en) Vaccine
ZA202210641B (en) Coronavirus vaccine
GB202004974D0 (en) Coronavirus vaccine
GB202217951D0 (en) Coronavirus vaccine
IL297070A (en) Coronavirus vaccine
GB201910794D0 (en) Vaccine
IL304441A (en) Measles-hiv or measles-htlv vaccine
GB202112149D0 (en) Shigellla vaccine
GB202016954D0 (en) Vaccine
GB202013262D0 (en) Vaccine Composition
GB201911636D0 (en) Vaccine
GB202318238D0 (en) Vaccine
GB202301244D0 (en) Vaccine
GB202218142D0 (en) Vaccine
GB202218115D0 (en) Vaccine
GB202218002D0 (en) Vaccine
GB202215414D0 (en) Vaccine
GB202207281D0 (en) Vaccine
GB202200963D0 (en) Vaccine
GB202318081D0 (en) Cornavirus vaccines
GB202317925D0 (en) Vaccines
GB202201060D0 (en) Beta-coronavirus vaccines
GB202119115D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)